The Punjab & Haryana High Court on Monday gave its nod to the merger of Ranbaxy Laboratories and Sun Pharmaceutical, dismissing objections raised by workers, the official liquidator, the Ministry of Corporate Affairs, and two unsecured creditors. The $4 billion deal had earlier received approval from company shareholders, the US Federal Trade Commission, and the Competition Commission of India.